Log in

PANACEABIO Panacea Biotec Limited NSE · India

Panacea Biotec (PANACEABIO) news

Panacea Biotec Limited is a public biotech or pharmaceutical company listed on NSE under the ticker PANACEABIO, recorded under India. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Latest Panacea Biotec news

We have not published a story on Panacea Biotec yet. When there is news, it will appear here.

Questions about Panacea Biotec

What is the ticker symbol of Panacea Biotec?

Panacea Biotec Limited trades under the ticker PANACEABIO on NSE.

Where is Panacea Biotec listed?

Panacea Biotec Limited is listed on NSE. Our directory also records these other listings: BSE:PANACEABIO.

Which country or territory is Panacea Biotec listed under?

Our directory records Panacea Biotec Limited under India.

What does Panacea Biotec do?

Our directory classifies Panacea Biotec Limited as: Pharmaceuticals: Major. This is a directory classification, not a description of the pipeline.

What is the ISIN of Panacea Biotec?

The ISIN recorded for Panacea Biotec Limited is INE922B01023.

Does aibio.space cover Panacea Biotec?

aibio.space lists Panacea Biotec Limited among 2,820 public biotech companies and publishes its news here as stories appear.

Which companies are similar to Panacea Biotec?

Companies in our directory listed in the same country and business area as Panacea Biotec: Eris Lifesciences, Venus Remedies, Indegene, FDC, Ambalal Sarabhai Enterprises, Kopran.

Investor discussion: Panacea Biotec

Members talk about Panacea Biotec (PANACEABIO). Reader posts, not aibio.space reporting, and not investment advice.

Rules
  1. Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
  2. Say whether you hold the stock. Every post states long, short or no position.
  3. No paid or sponsored posts. Do not post for anyone who pays or rewards you.
  4. No buy or sell calls and no price targets.
  5. No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
  6. No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open NSE:PANACEABIO on TradingView.

Listing details

Panacea Biotec Limited is a public biotech or pharmaceutical company listed on NSE under the ticker PANACEABIO, recorded under India. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Company
Panacea Biotec Limited
Ticker
PANACEABIO
Listing
NSE
Country or territory
India
Business scope
Pharmaceuticals: Major
ISIN
INE922B01023
Other listed symbols
BSE:PANACEABIO
Last quote in directory
2026-10-22
Directory source
Listing page

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction

Full desks

Every other company has a starter desk. Search above to open one.

Settings

Appearance
Text size
Motion

Stops the news strip and the share rollers.

Your choices are saved in this browser only.

Free membership

Read aibio.space in full, free

Subscribe with your email address to read every story, company desk and profile in full. It costs nothing. In return, you agree that we may email you, including offers. One click to unsubscribe.

No card, no password. With email, we send one message to confirm your address first. With Google or Facebook we receive only your email address. Not investment advice.